SI1845954T1 - Oralno razpadljiv sestavek olanzapina ali donepezila - Google Patents

Oralno razpadljiv sestavek olanzapina ali donepezila

Info

Publication number
SI1845954T1
SI1845954T1 SI200630726T SI200630726T SI1845954T1 SI 1845954 T1 SI1845954 T1 SI 1845954T1 SI 200630726 T SI200630726 T SI 200630726T SI 200630726 T SI200630726 T SI 200630726T SI 1845954 T1 SI1845954 T1 SI 1845954T1
Authority
SI
Slovenia
Prior art keywords
olanzapine
donepezil
orally disintegrating
disintegrating composition
composition
Prior art date
Application number
SI200630726T
Other languages
English (en)
Inventor
Vesna Kroselj
Sasa Kolaric
Renata Jakse
Miha Vrbinc
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Publication of SI1845954T1 publication Critical patent/SI1845954T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
SI200630726T 2005-01-14 2006-01-13 Oralno razpadljiv sestavek olanzapina ali donepezila SI1845954T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05000664A EP1681048A1 (en) 2005-01-14 2005-01-14 Orally disintegrating composition of olanzapine or donepezil
EP06701464A EP1845954B1 (en) 2005-01-14 2006-01-13 Orally disintegrating composition of olanzapine or donepezil
PCT/EP2006/000284 WO2006074951A2 (en) 2005-01-14 2006-01-13 Orally disintegrating composition of olanzapine or donepezil

Publications (1)

Publication Number Publication Date
SI1845954T1 true SI1845954T1 (sl) 2010-08-31

Family

ID=34933289

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630726T SI1845954T1 (sl) 2005-01-14 2006-01-13 Oralno razpadljiv sestavek olanzapina ali donepezila

Country Status (15)

Country Link
EP (2) EP1681048A1 (sl)
AT (1) ATE465719T1 (sl)
AU (1) AU2006205817A1 (sl)
DE (1) DE602006013940D1 (sl)
DK (1) DK1845954T3 (sl)
EA (1) EA013742B1 (sl)
ES (1) ES2344959T3 (sl)
HR (1) HRP20100399T1 (sl)
NO (1) NO20074087L (sl)
PL (1) PL1845954T3 (sl)
PT (1) PT1845954E (sl)
SI (1) SI1845954T1 (sl)
UA (1) UA89394C2 (sl)
WO (1) WO2006074951A2 (sl)
ZA (1) ZA200706692B (sl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879382B2 (en) 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
AU2007232098A1 (en) * 2006-03-31 2007-10-11 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
GB0614586D0 (en) * 2006-07-22 2006-08-30 Pliva Istrazivacki Inst D O O Pharmaceutical Formulation
HUE038022T4 (hu) * 2006-10-02 2023-02-28 Spepharm Ag Nem mukoadhezív filmdózisformák
US7998505B2 (en) * 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
EP2133096A4 (en) * 2007-03-13 2011-11-16 Dainippon Sumitomo Pharma Co IN THE MOUTHING TABLET
BRPI0817927A2 (pt) 2007-10-01 2015-04-07 Lesvi Laboratorios Sl Comprimidos orodispersiveis
CN101756917A (zh) * 2008-10-24 2010-06-30 北京科信必成医药科技发展有限公司 盐酸多奈哌齐口腔崩解片及其制备方法
WO2010070611A1 (en) * 2008-12-18 2010-06-24 Ranbaxy Laboratories Limited Atazanavir formulations
EP2198857A1 (en) 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
TR201002084A1 (tr) * 2010-03-19 2011-10-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre
WO2012014012A1 (es) * 2010-07-27 2012-02-02 Laboratorios Andrómaco S.A. Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
WO2013052114A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
US9055757B2 (en) 2011-10-05 2015-06-16 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
CN103987273B (zh) 2011-12-09 2018-07-27 Fmc有限公司 具有优良胶强度的共磨碎的稳定剂组合物
WO2014027975A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel orally administered pharmaceutical formulations
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CN104510717B (zh) * 2013-09-27 2019-02-05 江苏豪森药业集团有限公司 奥氮平口崩片及其制备方法
CN108261399A (zh) * 2016-12-30 2018-07-10 江苏豪森药业集团有限公司 奥氮平口腔崩解片及其制备方法
CN108926543A (zh) * 2017-05-26 2018-12-04 万全万特制药江苏有限公司 一种奥氮平口腔崩解片及其制备方法
CN109498544A (zh) * 2017-09-15 2019-03-22 万全万特制药江苏有限公司 稳定的奥氮平组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4107842B2 (ja) * 2000-03-01 2008-06-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ポリビニルアルコールを配合した速崩壊性錠剤
AU2002255196A1 (en) * 2002-04-18 2003-10-27 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
EP1845954A2 (en) 2007-10-24
ES2344959T3 (es) 2010-09-10
EP1681048A1 (en) 2006-07-19
PL1845954T3 (pl) 2010-10-29
PT1845954E (pt) 2010-08-02
EP1845954B1 (en) 2010-04-28
WO2006074951A2 (en) 2006-07-20
AU2006205817A1 (en) 2006-07-20
NO20074087L (no) 2007-10-09
UA89394C2 (uk) 2010-01-25
EA200701462A1 (ru) 2008-02-28
ZA200706692B (en) 2008-07-30
WO2006074951A3 (en) 2007-04-26
ATE465719T1 (de) 2010-05-15
DK1845954T3 (da) 2010-08-16
EA013742B1 (ru) 2010-06-30
DE602006013940D1 (de) 2010-06-10
HRP20100399T1 (hr) 2010-09-30

Similar Documents

Publication Publication Date Title
PL1845954T3 (pl) Kompozycja ulegająca rozpadowi po podaniu doustnym zawierająca olanzapinę lub donepezil
TW200621313A (en) Pharmaceutical compositions
TW200732296A (en) Novel compounds
WO2007052289A3 (en) Novel dispersible tablet composition
TW200734311A (en) New compounds
TW200745003A (en) Novel compounds
WO2007058583A3 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2007052023A3 (en) Novel compounds
WO2008076046A8 (en) Novel 2-amino-5, 5-diaryl-imidazol-4-ones
TW200630336A (en) Novel compounds
WO2008002683A3 (en) Polymorphous forms of carvedilol phosphate
TW200621690A (en) Novel compounds
WO2010049454A3 (en) Antimicrobial composition from copepods
TNSN07222A1 (en) Nematicidal compositions
HK1104795A1 (en) Dry formulations of aripiprazole
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
ME01172B (me) (2r,4ar,10br)-6-(2,6-dimetoksipiridin-3-il)-9-etoksi-8-metoksi-1,2,3,4,4a,10b-heksahidrofenantridin-2-ol, hci so
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
PL1831239T3 (pl) Sposób wytwarzania gamma-laktonu kwasu 17-hydroksy-6 beta, 7 beta,15 beta, 16 beta-bismetyleno-17 alpha-pregn-4-en-3-ono-21-karboksylowego i związki pośrednie kluczowe dla tego sposobu
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
TW200833371A (en) Process for solid formulations
TW200732345A (en) Niobium compound
WO2008035360A3 (en) Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil